What impact will the Ebola outbreak have on vaccine development for other neglected tropical diseases?

The 2014 Ebola outbreak in West Africa has devastated communities, leaving over 1000 dead according to WHO. Although arguably largely unreported in mainstream media until it started spreading outside of Africa, there is now lots of action in the Ebola space from companies throughout the world. It is unfortunate that it has taken this long for Ebola to get so …

NewLink Genetics Claims Most Advanced Ebola Vaccine Candidate

NewLink Genetics Claims Most Advanced Ebola Vaccine Candidate

American Pharmaceutical Company Could Soon Be Carrying Out Human Trials For Its Ebola Vaccine Candidate NewLink Genetics, an American pharmaceutical company based in Ames, Iowa will be continuing work on an Ebola vaccine candidate that has already been proven to be effective in primates. Although the company usually focuses on cancer research, it announced that the the United States Defense …

What you need to know: Vaccines in Emerging Markets

According to Decision Resources, "Emerging markets, particularly the BRIC markets (Brazil, Russia, India, and China), promise to be new engines for pharma growth in the face of faltering growth rates and growing challenges in the traditional stronghold major markets."  Below, we look at several issues dealing with vaccine R&D, market potential, and partnerships in emerging markets.  As these markets continue …

2020 vision for vaccines against HIV, tuberculosis and malaria

Rino Rappuoli, PhD, is Global Head of Vaccines Research at Novartis Vaccines and Diagnostics and is based in Siena, Italy.   In one of his most recent publications in Nature together with Alan Aderem, they discuss their 2020 vision for vaccines against HIV, tuberculosis and malaria.   Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five …